These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22506666)

  • 41. Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions.
    Potiron VA; Abderrahmani R; Giang E; Chiavassa S; Di Tomaso E; Maira SM; Paris F; Supiot S
    Radiother Oncol; 2013 Jan; 106(1):138-46. PubMed ID: 23321494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 in a preclinical model of adrenocortical carcinoma.
    Doghman M; Lalli E
    Mol Cell Endocrinol; 2012 Nov; 364(1-2):101-4. PubMed ID: 22960230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.
    Chen B; Crane C; He C; Gondek D; Agharkar P; Savellano MD; Hoopes PJ; Pogue BW
    Int J Cancer; 2008 Aug; 123(3):695-701. PubMed ID: 18498134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines.
    Masuda M; Shimomura M; Kobayashi K; Kojima S; Nakatsura T
    Oncol Rep; 2011 Nov; 26(5):1273-9. PubMed ID: 21725613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.
    Domagala A; Stachura J; Gabrysiak M; Muchowicz A; Zagozdzon R; Golab J; Firczuk M
    BMC Cancer; 2018 Feb; 18(1):210. PubMed ID: 29463237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma.
    Gan ZY; Fitter S; Vandyke K; To LB; Zannettino AC; Martin SK
    Eur J Haematol; 2015 Apr; 94(4):343-54. PubMed ID: 25179233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3-kinase inhibitor BEZ235 and the PI3-kinase inhibitor BKM120 in hepatocellular carcinoma.
    Kirstein MM; Boukouris AE; Pothiraju D; Buitrago-Molina LE; Marhenke S; Schütt J; Orlik J; Kühnel F; Hegermann J; Manns MP; Vogel A
    Liver Int; 2013 May; 33(5):780-93. PubMed ID: 23489999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted inhibition of p38MAPK-enhanced autophagy in SW620 cells resistant to photodynamic therapy-induced apoptosis.
    Xue Q; Wang P; Wang X; Zhang K; Liu Q
    Lasers Med Sci; 2015 Sep; 30(7):1967-75. PubMed ID: 26254783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.
    Hu Z; Rao B; Chen S; Duanmu J
    BMC Cancer; 2010 May; 10():235. PubMed ID: 20504328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic Enhancement of Verteporfin-mediated Photodynamic Therapy by mTOR Inhibitors.
    Kraus D; Palasuberniam P; Chen B
    Photochem Photobiol; 2020 Mar; 96(2):358-364. PubMed ID: 31769520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells.
    Rodríguez ME; Catrinacio C; Ropolo A; Rivarola VA; Vaccaro MI
    Photochem Photobiol Sci; 2017 Nov; 16(11):1631-1642. PubMed ID: 28936522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoptotic and autophagic responses to photodynamic therapy in 1c1c7 murine hepatoma cells.
    Andrzejak M; Price M; Kessel DH
    Autophagy; 2011 Sep; 7(9):979-84. PubMed ID: 21555918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukocyte-endothelial cell interaction is necessary for photodynamic therapy induced vascular permeabilization.
    Debefve E; Mithieux F; Perentes JY; Wang Y; Cheng C; Schaefer SC; Ruffieux C; Ballini JP; Gonzalez M; van den Bergh H; Ris HB; Lehr HA; Krueger T
    Lasers Surg Med; 2011 Sep; 43(7):696-704. PubMed ID: 22057497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of p38MAPK in apoptosis and autophagy responses to photodynamic therapy with Chlorin e6.
    Xue Q; Wang X; Wang P; Zhang K; Liu Q
    Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):84-91. PubMed ID: 25528442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invention of a novel photodynamic therapy for tumors using a photosensitizing PI3K inhibitor.
    Hayashida Y; Ikeda Y; Sawada K; Kawai K; Kato T; Kakehi Y; Araki N
    Int J Cancer; 2016 Aug; 139(3):700-11. PubMed ID: 26989815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice.
    Muchowicz A; Wachowska M; Stachura J; Tonecka K; Gabrysiak M; Wołosz D; Pilch Z; Kilarski WW; Boon L; Klaus TJ; Golab J
    Eur J Cancer; 2017 Sep; 83():19-27. PubMed ID: 28709135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice.
    Biswas R; Mondal A; Ahn JC
    J Photochem Photobiol B; 2015 Jul; 148():118-127. PubMed ID: 25910816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Anticancer Effects of Radachlorin-mediated Photodynamic Therapy in the Human Endometrial Adenocarcinoma Cell Line HEC-1-A.
    Kim SM; Rhee YH; Kim JS
    Anticancer Res; 2017 Nov; 37(11):6251-6258. PubMed ID: 29061808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photodynamic therapy induced cell death of hormone insensitive prostate cancer PC-3 cells with autophagic characteristics.
    Xu DD; Lam HM; Hoeven R; Xu CB; Leung AW; Cho WC
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):278-87. PubMed ID: 23993854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation.
    Rizzi M; Tonello S; Estevão BM; Gianotti E; Marchese L; Renò F
    J Photochem Photobiol B; 2017 Feb; 167():1-6. PubMed ID: 28039784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.